Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Chicago, IL
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Kansas City, KA
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Lexington, KY
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Advance, NC
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Advance, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Tulsa, OK
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Roanoke, VA
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated:  6/24/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Status: Enrolling
Updated: 6/24/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease: A Randomized, Double-blind, Crossover Pilot Study
Status: Enrolling
Updated:  6/26/2013
VA Medical Center, Philadelphia
mi
from
Philadelphia, PA
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease: A Randomized, Double-blind, Crossover Pilot Study
Status: Enrolling
Updated: 6/26/2013
VA Medical Center, Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Birmingham, AL
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Fountain Valley, CA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Irvine, CA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Pasadena, CA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Sunnyvale, CA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Gainesville, FL
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Miami, FL
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Ormond Beach, FL
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Sunrise, FL
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Annapolis, MD
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Annapolis, MD
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Lincoln, NE
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Syracuse, NY
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Mineola, NY
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Charlotte, NC
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Raleigh, NC
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Salisbury, NC
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Toledo, OH
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Tulsa, OK
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Cordova, TN
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Cordova, TN
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Memphis, TN
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Houston, TX
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Richmond, VA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Kirkland, WA
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
A Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses (0.5, 1.0, and 2.0 mg) of Rasagiline Administered to Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  8/22/2013
Teva Investigational Site 10738
mi
from
Glendale, CA
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
A Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses (0.5, 1.0, and 2.0 mg) of Rasagiline Administered to Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 8/22/2013
Teva Investigational Site 10738
mi
from
Glendale, CA
Click here to add this to my saved trials
DBS Frequency on Swallowing Function in Parkinson's Disease
Effects of the Stimulation Frequency of STN DBS on Swallowing Function in Patients With Parkinson's Disease
Status: Enrolling
Updated:  9/4/2013
University of Chicago
mi
from
Chicago, IL
DBS Frequency on Swallowing Function in Parkinson's Disease
Effects of the Stimulation Frequency of STN DBS on Swallowing Function in Patients With Parkinson's Disease
Status: Enrolling
Updated: 9/4/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
Phase I Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a in Subjects With Parkinson Disease and Healthy Subjects
Status: Enrolling
Updated:  9/18/2013
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
Phase I Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a in Subjects With Parkinson Disease and Healthy Subjects
Status: Enrolling
Updated: 9/18/2013
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease
Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated:  9/18/2013
Providence VA Medical Center
mi
from
Providence, RI
Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease
Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated: 9/18/2013
Providence VA Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Status: Enrolling
Updated:  10/10/2013
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Expiratory Muscle Training for Persons With Neurodegenerative Disease
Status: Enrolling
Updated: 10/10/2013
North Florida/South Georgia Veterans Health System
mi
from
Gainesville, FL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Arizona Neurological Institute
mi
from
Phoenix, AZ
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Arizona Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Pacific Neuroscience Medical Group
mi
from
Oxnard, CA
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Pacific Neuroscience Medical Group
mi
from
Oxnard, CA
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
San Francisco Clinical Research Center
mi
from
San Francisco, CA
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
The Parkinson's Institute
mi
from
Sunnyvale, CA
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
The Parkinson's Institute
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Parkinson's Disease and Movement Disorder Center
mi
from
Boca Raton, FL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Parkinson's Disease and Movement Disorder Center
mi
from
Boca Raton, FL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Neurologic Consultants P.A.
mi
from
Ft Lauderdale, FL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Neurologic Consultants P.A.
mi
from
Ft Lauderdale, FL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
University of Florida
mi
from
Gainesville, FL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Parkinson's Disease Treatment Center of SW Florida
mi
from
Port Charlotte, FL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Parkinson's Disease Treatment Center of SW Florida
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated:  10/28/2013
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Status: Enrolling
Updated: 10/28/2013
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
Click here to add this to my saved trials